MedPath

umella test for detection of pre-eclampsia

Not Applicable
Conditions
Pre-eclampsia
Pregnancy and Childbirth
Registration Number
ISRCTN13430018
Lead Sponsor
Advanced Global Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
Female
Target Recruitment
400
Inclusion Criteria

Potential participants include cases with a risk of preeclampsia who meet the following criteria at the time of enrolment:
1. Age of 18 years or older
2. Singleton or twin pregnancy
3. Gestational age between 24+0 to 36+6 weeks
4. Able to provide informed written consent
5. Planned delivery at the study site or where maternal and newborn records will be available to the investigator for review

Cases with a risk of preeclampsia will be identified based on clinical and medical history criteria as follows:

Clinical risk factors:
1. Systolic blood pressure =130 mmHg on 1 or more occasion
2. Diastolic blood pressure =80 mmHg on 1 or more occasion
3. Elevated urinary protein:
3.1. Urine protein dipstick test 1+ or more
3.2. Urinary protein/creatinine ratio =0.30 mg/mg
3.3. Urinary protein =300 mg per day in timed collection
4. New onset low platelet count =100,000 x 109/L
5. New onset elevated serum creatinine =1.0 mg/dL
6. New onset transaminase elevation above limits of normal for local laboratory
7. New-onset headache unresponsive to medication and not accounted for by alternative diagnoses
8. New onset visual symptoms
9. Fetal growth restriction with estimated fetal weight below 10th percentile

Historical/obstetrical risk factors:
1. History of preeclampsia
2. Multifetal pregnancy
3. Pre-existing hypertension
4. Pre-gestational diabetes mellitus
5. Pre-existing renal disease

Exclusion Criteria

1. Diagnostic criteria for preeclampsia already met at the time of enrolment
2. Delivery is planned prior to 37+0 weeks of gestation for reasons other than preeclampsia

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath